Difference between revisions of "MSK Biomarker Ctte"

From QIBA Wiki
Jump to: navigation, search
Line 9: Line 9:
  
 
'''Approved call summaries:'''
 
'''Approved call summaries:'''
 +
*[[Media:2018_01-16_QIBA_MSK_Biomarker_Cmte_Call_Summary-FINAL.pdf|January 16, 2018]]
 
*[[Media:2017_11-21_QIBA_MSK_Biomarker_Cmte_Call_Summary-FINAL.pdf|November 21, 2017]]
 
*[[Media:2017_11-21_QIBA_MSK_Biomarker_Cmte_Call_Summary-FINAL.pdf|November 21, 2017]]
 
*[[Media:2017_10-17_QIBA_MSK_Biomarker_Cmte_Call_Summary-FINAL.pdf|October 17, 2017]]
 
*[[Media:2017_10-17_QIBA_MSK_Biomarker_Cmte_Call_Summary-FINAL.pdf|October 17, 2017]]

Revision as of 16:41, 21 February 2018

Co-chairs: Thomas M. Link, MD, PhD; Xiaojuan Li, PhD
Secretary: Susan Weinmann

The MSK Biomarker Committee seeks to develop a quantitative Profile for MSK.

Meetings

Approved call summaries:

MSK Biomarker Committee Call Summaries Archive

Working Documents

Statistical Reference Documents

Workflow Documents

Reference Materials